Applications including "Benzoic acid"

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC Technical Note InertSustain AQ-C18
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch InertSustain C18
LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB031 - Analysis of Preservatives and Sweetener -

LC InertSearch InertSustain Phenyl
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain AQ-C18
GA348 - Analysis of Paraoxybenzoic acid esters -

GC InertSearch InertCap 5
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain C18
LB853 - Analysis of p-Hydroxybenzoic acid esters -

LC InertSearch InertSustain C18
LB852 - Analysis of Benzoic acid -

LC InertSearch InertSustain C18
LB834 - Analysis of Paraoxybenzoic acid esters -

LC InertSearch InertSustain C18
LB828 - Analysis of Chloroprocaine Hydrochloride -

LC InertSearch InertSustain C18
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LC InertSearch Inertsil ODS-HL
LB721 - Analysis of Acetaminophen -

LC InertSearch InertSustain C18
LB701 - Analysis of chlorpheniramine maleate -

LC InertSearch Inertsil ODS-4
LB700 - Analysis of acetaminophen -

LC InertSearch InertSustain C18
LB693 - Analysis of Preservatives and Sweetener -

LC InertSearch InertCore Plus C18
LB659 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LB658 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LC InertSearch Inertsil ODS-HL
LT094 - Analysis of Preservatives in Foods -Third Report- -

LC Technical Note Inertsil ODS-4
LT076 - Analysis of Preservatives in Foods - Second Report -

LC Technical Note Inertsil ODS-3
LT075 - HPLC Analysis of Preservatives in Foods -

LC Technical Note Inertsil ODS-3
LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LC Technical Note
LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch InertSustain AQ-C18
LB562 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LC InertSearch Inertsil ODS-HL
LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain AQ-C18
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LC InertSearch InertSustain C18
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LC InertSearch InertSustain C18
LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LC InertSearch InertSustain C18
LB511 - Analysis of Parabens, Estradiol and Progesterone -

LC InertSearch InertSustainSwift C18
LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LC InertSearch InertSustain Cyano
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LC InertSearch InertSustain C18
LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LC InertSearch Inertsil ODS-3
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LC InertSearch InertSustain C8
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB404 - Analysis of Preservatives and Sweetener (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB403 - Analysis of Preservatives and Sweetener (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB395 - Analysis of Acetaminophen and Caffeine -

LC InertSearch InertSustainSwift C18
LB338 - Analysis of Chlorhexidine gluconate solution -

LC InertSearch Inertsil ODS-4
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch InertSustain C18
LB313 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LC InertSearch Inertsil ODS-3
LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch InertSustain C18
LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LC InertSearch Inertsil ODS-3
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LC InertSearch Inertsil ODS-2
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LC InertSearch InertSustain C18
LB242 - Analysis of Preservatives and Sweetener (Inertsil Ph) -

LC InertSearch Inertsil Ph
LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB240 - Analysis of Preservatives and Sweetener (InertSustain Phenyl) -

LC InertSearch InertSustain Phenyl
LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB238 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LC InertSearch InertSustain C18
LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB235 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LC InertSearch InertSustain Phenylhexyl
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LC InertSearch InertSustain C18
LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LC InertSearch Inertsil WP300 C18
LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch Inertsil WP300 C18
LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB105 - Analysis of Pitavastatin calcium -

LC InertSearch Inertsil ODS-4
LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LC InertSearch InertSustain C18
LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -

LC InertSearch InertSustain C18
LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -

LC InertSearch InertSustain C18
LB048 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB047 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB046 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB045 - Analysis of Preservatives (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB028 - Analysis of Pitavastatin Calcium -

LC InertSearch InertSustain C18
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -

LC InertSearch InertSustain C18
LA972 - Analysis of Loxoprofen- InertSustain C18(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LA971 - Analysis of Loxoprofen- Inertsil ODS-SP(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA970 - Analysis of Salicylic acid(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-P
LA955 - Analysis of Parabens (InertSustain C18) -

LC InertSearch InertSustain C18
LA954 - Analysis of Parabens (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA953 - Analysis of Parabens (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA952 - Analysis of Parabens (InertSustain C18) -

LC InertSearch InertSustain C18
LA951 - Analysis of Parabens (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA950 - Analysis of Parabens (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA947 - Analysis of Parabens (InertSustain C18) -

LC InertSearch InertSustain C18
LA946 - Analysis of Parabens (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA909 - Analysis of Indometacin (InertSustain C18) -

LC InertSearch InertSustain C18
LA905 - Analysis of Glycyrrhiza Standard (InertSustain C18) -

LC InertSearch InertSustain C18
LA899 - Analysis of Rifampicin(Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil C8-4
LA847 - Analysis of Indomethacin (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LA846 - Analysis of Indomethacin (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA845 - Analysis of Indomethacin (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LA825 - Analysis of Indomethacine -

LC InertSearch MonoClad C18-HS
LA821 - Analysis of Aromatic carboxylic acid -

LC InertSearch MonoClad C18-HS
LA818 - Analysis of Preservatives -

LC InertSearch MonoClad C18-HS
LA751 - Analysis of Phenoxyacetic acid and benzoic acid -

LC InertSearch Inertsil ODS-EP
LA730 - Analysis of Tranexamic acid -

LC InertSearch Inertsil ODS-3
LA713 - Analysis of Food preservatives -

LC InertSearch Inertsil ODS-3
LA685 - Analysis of Preservatives -

LC InertSearch Inertsil ODS-4
LA628 - Analysis of Phenolic Acid by HPLC-ECD -

LC InertSearch Inertsil ODS-3
LA626 - Analysis of para-hydroxybenzoates -

LC InertSearch Inertsil ODS-3
LA625 - Analysis of Chemical additives in food -

LC InertSearch Inertsil ODS-3
LA550 - Analysis of Glycyrrhiza Standard (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA545 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil ODS-3
LA542 - Analysis of Benzoic acid and Phenoxyacetic acid -

LC InertSearch Inertsil CN-3
LA541 - Analysis of Phenoxyacetic acid and Benzoic acid -

LC InertSearch Inertsil ODS-SP
LA540 - Analysis of Phenoxyacetic acid and Benzoic acid -

LC InertSearch Inertsil ODS-EP
LA354 - Analysis of Amitriptyline -

LC InertSearch Inertsil C8-3
LA353 - Analysis of Amitriptyline -

LC InertSearch Inertsil ODS-3V
LA212 - Analysis of Cortisone acetate -

LC InertSearch Inertsil ODS-3
LA205 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil ODS-P
LA199 - Indometacin -

LC InertSearch Inertsil ODS-3
LA197 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil Ph-3
LA196 - Analysis of Glycyrrhizin -

LC InertSearch Inertsil ODS-3V
LA195 - Analysis of Phenothiazines -

LC InertSearch Inertsil ODS-3V
LA188 - Analysis of Estriol -

LC InertSearch Inertsil ODS-3V
LA186 - Analysis of Dinoprost -

LC InertSearch Inertsil ODS-3V
LA185 - Analysis of Deferoxamine mesilate -

LC InertSearch Inertsil ODS-3V
LA184 - Analysis of Alprostadil -

LC InertSearch Inertsil ODS-3V
LA177 - Analysis of Baclofen -

LC InertSearch Inertsil ODS-3V
LA176 - Analysis of Betamethasone -

LC InertSearch Inertsil ODS-3V
LA175 - Analysis of Betamethasone sodium phosphate -

LC InertSearch Inertsil ODS-3V
LA173 - Analysis of Bisacodyl -

LC InertSearch Inertsil ODS-3V
LA172 - Analysis of Diclofenac sodium -

LC InertSearch Inertsil ODS-3V
LA171 - Analysis of Fluocinolone acetonide(column select) -

LC InertSearch Inertsil ODS-3V
LA170 - Analysis of Fluocinolone acetonide -

LC InertSearch Inertsil ODS-3V
LA166 - Analysis of Prednisolone succinate -

LC InertSearch Inertsil ODS-3V
LA164 - Analysis of Reserpine -

LC InertSearch Inertsil ODS-3V
LA122 - Aromatic Organic Acids -

LC InertSearch Inertsil ODS-3V
LA106 - Aromatic Organic acids -

LC InertSearch Inertsil C8
LA105 - Analysis of Parabens -

LC InertSearch Inertsil Diol
LA104 - Analysis of Parabens -

LC InertSearch Inertsil SIL-100A
LA103 - Analysis of Parabens -

LC InertSearch Inertsil Diol
LA089 - Analysis of Preservatives -

LC InertSearch Inertsil ODS-3V
LA088 - Analysis of Preservatives -

LC InertSearch Inertsil Ph-3
LA082 - Analysis of Food additives -

LC InertSearch Inertsil ODS-3V
LA081 - Analysis of Food additives -

LC InertSearch Inertsil ODS-3V
LA056 - Food additives -

LC InertSearch Inertsil Ph
GA169 - Organic acids -

GC InertSearch InertCap 1

Applications including "Benzoic acid"

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LB031 - Analysis of Preservatives and Sweetener -

LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

GA348 - Analysis of Paraoxybenzoic acid esters -

LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LB853 - Analysis of p-Hydroxybenzoic acid esters -

LB852 - Analysis of Benzoic acid -

LB834 - Analysis of Paraoxybenzoic acid esters -

LB828 - Analysis of Chloroprocaine Hydrochloride -

LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LB721 - Analysis of Acetaminophen -

LB701 - Analysis of chlorpheniramine maleate -

LB700 - Analysis of acetaminophen -

LB693 - Analysis of Preservatives and Sweetener -

LB659 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LB658 - Analysis of Tamsulosin hydrochloride (Under the Condition of the Japanese harmacopoeia) -

LT094 - Analysis of Preservatives in Foods -Third Report- -

LT076 - Analysis of Preservatives in Foods - Second Report -

LT075 - HPLC Analysis of Preservatives in Foods -

LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LB563 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LB562 - Analysis of Steviol (Under the Condition of the JPE (Japanese Pharmaceutical Excipients), Purified Stevia Extract (4) Steviol) -

LB560 - Analysis of Advantame (Under the Condition of the JSFA-IX (Japanese Standards of Food Additives)) -

LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LB517 - Analysis of Glycyrrhizic acid (Under the Condition of the Japanese Standards of Quasi-drug Ingredients, Glycyrrhiza Extracted Powder) -

LB511 - Analysis of Parabens, Estradiol and Progesterone -

LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LB460 - Analysis of Estradiol (Under the Condition of USP 39-NF34) -

LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LB404 - Analysis of Preservatives and Sweetener (Inertsil ODS-SP) -

LB403 - Analysis of Preservatives and Sweetener (Inertsil ODS-4) -

LB402 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LB401 - Analysis of Preservatives and Sweetener (InertSustain AQ-C18) -

LB395 - Analysis of Acetaminophen and Caffeine -

LB338 - Analysis of Chlorhexidine gluconate solution -

LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LB314 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LB313 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JSFA-VIII (Japanese Standards of Food Additives)) -

LB312 - Analysis of Acesulfame potassium (InertSustain C18) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LB311 - Analysis of Acesulfame potassium (Inertsil ODS-3) (Under the Condition of the JPE (Japanese Pharmaceutical Excipients)) -

LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LB242 - Analysis of Preservatives and Sweetener (Inertsil Ph) -

LB241 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LB240 - Analysis of Preservatives and Sweetener (InertSustain Phenyl) -

LB239 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LB238 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LB237 - Analysis of Preservatives and Sweetener (InertSustain C18) -

LB236 - Analysis of Preservatives and Sweetener (InertSustainSwift C18) -

LB235 - Analysis of Preservatives and Sweetener (InertSustain Phenylhexyl) -

LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB105 - Analysis of Pitavastatin calcium -

LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LB084 - Analysis of Olmesartan medoxomil (Under the Condition of United States Pharmacopeia 35-NF30) -